The Experts below are selected from a list of 27663 Experts worldwide ranked by ideXlab platform
Laura Liberman - One of the best experts on this subject based on the ideXlab platform.
-
percutaneous imaging guided core Breast Biopsy
American Journal of Roentgenology, 2012Co-Authors: Laura LibermanAbstract:1191 ercutaneous imaging-guided Breast Biopsy is increasingly an alternative to surgical Biopsy for the histologic assessment of nonpalpable Breast lesions [1–17]. Percutaneous imagingguided Biopsy is most often performed under stereotactic [1–15] or sonographic guidance [14–17] (Fig. 1); some investigators report preliminary experience with percutaneous Biopsy guided by MR imaging [18–27]. Early work with percutaneous Breast Biopsy primarily involved fine-needle aspiration, but large-core Biopsy is now preferred at most centers in this country because of its better characterization of benign and malignant lesions and lower frequency of insufficient samples [28, 29]. This article will review the state of percutaneous imaging-guided core Breast Biopsy as we face the new millennium, including its advantages, limitations, controversies, and future directions.
-
Underestimation of DCIS at MRI-guided vacuum-assisted Breast Biopsy.
American Journal of Roentgenology, 2007Co-Authors: Jung-min Lee, Jennifer B. Kaplan, Melissa Murray, Marzena Mazur-grbec, Tade Tadic, Damir Stimac, Laura LibermanAbstract:OBJECTIVE. The study objective was to assess the rate of underestimation of ductal carcinoma in situ (DCIS) at MRI-guided 9-gauge vacuum-assisted Breast Biopsy.MATERIALS AND METHODS. An institutional review board-approved retrospective review was performed of 373 consecutive lesions that had undergone MRI vacuum-assisted Breast Biopsy. In 34 lesions with subsequent surgery, vacuum-assisted Breast Biopsy yielded DCIS without frank microinvasion or invasion. DCIS underestimates were lesions for which vacuum-assisted Breast Biopsy yielded DCIS without frank microinvasion or invasion at Biopsy and surgery yielded invasive cancer. Records and pathology findings were reviewed.RESULTS. Among 34 lesions, vacuum-assisted Breast Biopsy histology was DCIS in 29 and DCIS with possible microinvasion in five. Of 29 lesions yielding DCIS at MRI vacuum-assisted Breast Biopsy, surgical excision revealed invasive cancer in five (17%; 95% CI, 6-36%). The DCIS underestimation rate was significantly higher in lesions 6 cm or ...
-
percutaneous image guided core Breast Biopsy
Radiologic Clinics of North America, 2002Co-Authors: Laura LibermanAbstract:Percutaneous image-guided core Biopsy is an accurate, fast, minimally invasive, and less expensive alternative to surgery for the diagnosis of Breast lesions. Percutaneous core Biopsy is usually performed under stereotactic or ultrasound guidance, using an automated needle or vacuum-assisted Biopsy probe. Use of percutaneous core Biopsy spares the need for surgery in most women with benign disease and expedites treatment in women with Breast cancer. This article reviews advantages, limitations, controversies, and future directions in percutaneous image-guided core Breast Biopsy.
-
clinical management issues in percutaneous core Breast Biopsy
Radiologic Clinics of North America, 2000Co-Authors: Laura LibermanAbstract:Percutaneous image-guided core Breast Biopsy is being increasingly used to diagnose Breast lesions. Percutaneous Biopsy is faster, less invasive, and less expensive than surgical Biopsy. 23,46,50,61,62 Less tissue is removed at percutaneous Biopsy, resulting in no deformity in the Breast and minimal to no scarring on subsequent mammograms. 11,40 Percutaneous core Biopsy can obviate the need for surgery in women with benign lesions, 46,61,62,89 and can reduce the number of surgical procedures performed in women with Breast cancer. 46,61,62,64,65,93 Although the advantages of percutaneous image-guided core Biopsy have been demonstrated in numerous studies, controversies remain. Current clinical management issues in percutaneous image-guided Breast Biopsy include patient selection, equipment and technique, complete excision versus sampling, epithelial displacement, and management after percutaneous Biopsy of the Breast.
Steve H Parker - One of the best experts on this subject based on the ideXlab platform.
-
Methods for Analysis of One-Step Breast Biopsy Programs
The Breast Journal, 1998Co-Authors: Fred Burbank, Steve H ParkerAbstract:: Many Breast care centers have introduced image-guided Breast Biopsy programs. These newer one-step Biopsy programs need to be evaluated and compared to localization and open surgical Biopsy to ensure maintream acceptance. The authors describe a method that compares the histology from an image-guided Breast Biopsy with the histology from an open surgical Biopsy using a traditional 4 × 4 table. The 16 conventional cells identified in the 4 × 4 table are simplified into three clinically relevant categories. In addition, eight numerically defined Biopsy program performance measurements are presented.
-
atypical ductal hyperplasia diagnosed at stereotactic Breast Biopsy improved reliability with 14 gauge directional vacuum assisted Biopsy
Radiology, 1997Co-Authors: Roger J Jackman, Steve H Parker, Fred Burbank, Walter P Evans, Mary C Lechner, Thomas R Richardson, Irena Tocino, Alan B WrayAbstract:PURPOSE: To compare histologic findings of atypical ductal hyperplasia (ADH) at 14-gauge, directional, vacuum-assisted Breast Biopsy (hereafter, vacuum-assisted Biopsy) and at 14-gauge, automated, large-core Breast Biopsy (hereafter, large-core Biopsy) with findings at histologic examination after surgical Biopsy. MATERIALS AND METHODS: Nonpalpable Breast lesions were diagnosed as ADH at histologic examination after vacuum-assisted Biopsy in 88 lesions in seven institutions and after large-core Biopsy in 55 previously reported lesions. Histologic findings at subsequent surgical Biopsy were compared for the presence of carcinoma. RESULTS: On the basis of histologic findings of carcinoma at surgical Biopsy, the diagnosis of ADH was not correct in 26 (48%) of 54 lesions sampled at large-core Biopsy and in 13 (18%) of 74 lesions sampled at vacuum-assisted Biopsy (Fisher exact test, P < .0004). More tissue specimens were obtained at vacuum-assisted Biopsy (mean, 15.8 specimens) than at large-core Biopsy (mean,...
-
percutaneous large core Breast Biopsy a multi institutional study
Radiology, 1994Co-Authors: Steve H Parker, Fred Burbank, Roger J Jackman, C J Aucreman, G Cardenosa, T M Cink, Jr Jl Coscia, G W Eklund, Rd Wp Evans, P R GarverAbstract:PURPOSE: To assess the reliability and reproducibility of automated large-core Breast Biopsy. MATERIALS AND METHODS: A consortium of 20 institutions reported, in a standardized fashion, their core Breast Biopsy data. All biopsies were performed with "long-throw" (2.3-cm) automated core Biopsy devices fitted with 14-gauge needles. Needle guidance was accomplished by means of either a dedicated, stereotaxic device, in which the patient lies in the prone position, or high-frequency electronically focused ultrasound equipment. RESULTS: The data in 6,152 lesions were gathered. Clinical or surgical follow-up was available in 3,765 lesions; 1,363 of these lesions were subsequently surgically excised, and the core histologic study showed cancer in 910 lesions, mammary intraepithelial neoplasia in 173 lesions, and benign disease in 280 lesions. In these 280 lesions, there were 15 false-negative core biopsies. CONCLUSION: The data show that percutaneous large-core Breast Biopsy is a reproducible and reliable altern...
-
us guided automated large core Breast Biopsy
Radiology, 1993Co-Authors: Steve H Parker, W E Jobe, Wayne F. Yakes, Mark A Dennis, A T Stavros, K K Johnson, J E Truell, J G Price, A B Kortz, D G ClarkAbstract:To evaluate the efficacy of ultrasound (US)-guided automated large-core percutaneous needle Breast Biopsy, Biopsy of 181 ultrasonographically suspicious Breast lesions was performed by using a long-throw Biopsy gun and 14-gauge needles with continuous US guidance. A "freehand" technique with either 5.0- or 7.5-MHz linear-array transducers was used. Needle core diagnoses were compared with surgical diagnoses in the 49 lesions subsequently surgically excised. The remaining 132 cases were followed for 12-36 months. Agreement between needle-core and surgical diagnoses in the 49 lesions was 100%. This group included 34 cancers (28 infiltrating ductal, two mucinous, one mixed infiltrating ductal and lobular, and one each of intraductal, infiltrating lobular, and tubular carcinoma). To date, no cancers have been found in the other 132 cases. The procedure time averaged 20 minutes, and no complications occurred. With an accuracy approaching that of excisional Biopsy, US-guided needle core Biopsy provides an alternative to surgery.
S. Uzan - One of the best experts on this subject based on the ideXlab platform.
-
Histology after lumpectomy in women with epithelial atypia on stereotactic vacuum assisted Breast Biopsy
EJSO - European Journal of Surgical Oncology, 2010Co-Authors: O. Graesslin, M. Antoine, J. Chopier, J.y. Seror, A. Flahault, P. Callard, E. Daraï, S. UzanAbstract:Large-core needle Biopsy of the Breast (LCNB) and vacuum-assisted Breast Biopsy (VABB) are widely used as alternatives to open surgical Biopsy (OSB) for initial diagnosis of mammographic abnormalities. Between 18% and 80% of cases in which such specimens show atypical lobular hyperplasia (ALH) or atypical ductal hyperplasia (ADH) are found to be malignant at surgery.
Roger J Jackman - One of the best experts on this subject based on the ideXlab platform.
-
atypical ductal hyperplasia diagnosed at stereotactic Breast Biopsy improved reliability with 14 gauge directional vacuum assisted Biopsy
Radiology, 1997Co-Authors: Roger J Jackman, Steve H Parker, Fred Burbank, Walter P Evans, Mary C Lechner, Thomas R Richardson, Irena Tocino, Alan B WrayAbstract:PURPOSE: To compare histologic findings of atypical ductal hyperplasia (ADH) at 14-gauge, directional, vacuum-assisted Breast Biopsy (hereafter, vacuum-assisted Biopsy) and at 14-gauge, automated, large-core Breast Biopsy (hereafter, large-core Biopsy) with findings at histologic examination after surgical Biopsy. MATERIALS AND METHODS: Nonpalpable Breast lesions were diagnosed as ADH at histologic examination after vacuum-assisted Biopsy in 88 lesions in seven institutions and after large-core Biopsy in 55 previously reported lesions. Histologic findings at subsequent surgical Biopsy were compared for the presence of carcinoma. RESULTS: On the basis of histologic findings of carcinoma at surgical Biopsy, the diagnosis of ADH was not correct in 26 (48%) of 54 lesions sampled at large-core Biopsy and in 13 (18%) of 74 lesions sampled at vacuum-assisted Biopsy (Fisher exact test, P < .0004). More tissue specimens were obtained at vacuum-assisted Biopsy (mean, 15.8 specimens) than at large-core Biopsy (mean,...
-
percutaneous large core Breast Biopsy a multi institutional study
Radiology, 1994Co-Authors: Steve H Parker, Fred Burbank, Roger J Jackman, C J Aucreman, G Cardenosa, T M Cink, Jr Jl Coscia, G W Eklund, Rd Wp Evans, P R GarverAbstract:PURPOSE: To assess the reliability and reproducibility of automated large-core Breast Biopsy. MATERIALS AND METHODS: A consortium of 20 institutions reported, in a standardized fashion, their core Breast Biopsy data. All biopsies were performed with "long-throw" (2.3-cm) automated core Biopsy devices fitted with 14-gauge needles. Needle guidance was accomplished by means of either a dedicated, stereotaxic device, in which the patient lies in the prone position, or high-frequency electronically focused ultrasound equipment. RESULTS: The data in 6,152 lesions were gathered. Clinical or surgical follow-up was available in 3,765 lesions; 1,363 of these lesions were subsequently surgically excised, and the core histologic study showed cancer in 910 lesions, mammary intraepithelial neoplasia in 173 lesions, and benign disease in 280 lesions. In these 280 lesions, there were 15 false-negative core biopsies. CONCLUSION: The data show that percutaneous large-core Breast Biopsy is a reproducible and reliable altern...
S H Parker - One of the best experts on this subject based on the ideXlab platform.
-
Percutaneous large core Breast Biopsy.
Cancer, 1994Co-Authors: S H ParkerAbstract:Surgical excision Biopsy is considered by many to be the "gold standard" for the diagnosis of Breast lesions. Fine needle aspiration Biopsy is used by some radiologists and other physicians in an attempt to diagnose Breast lesions nonsurgically. To overcome the drawbacks associated with both of these methods, the author and his coworkers have developed the image-guided automated large-core Breast Biopsy method. All biopsies are performed using either a dedicated, prone stereotactic device or high-resolution near-field ultrasound equipment for needle guidance. A "long-throw" (2.3 cm) automated core Biopsy device fitted with a 14-gauge needle is used to acquire five or more core samples from each lesion for histologic evaluation. The ability of percutaneous, image-guided, large-core Breast Biopsy to provide the correct histologic diagnosis of a Breast lesion is equivalent to open surgical Biopsy. The cost of large-core Breast Biopsy is one half to one quarter that of surgical Biopsy. No adverse cosmesis or mammographic pseudolesion results. In an era of increasing cost restraints in health care, it is important to identify means by which the level of patient care can be maintained or improved at lesser cost. Percutaneous large-core Breast Biopsy provides that opportunity in the diagnosis of Breast disease and should prove to be a cost-effective, reliable, and expedient alternative to surgical Biopsy.
-
Stereotactic Breast Biopsy with a Biopsy gun
Radiology, 1990Co-Authors: S H Parker, J D Lovin, W E Jobe, J M Luethke, K D Hopper, Wayne F. Yakes, B J BurkeAbstract:One hundred three patients underwent stereotactic Breast Biopsy with an 18-, 16-, or 14-gauge cutting needle and a Biopsy gun. After Biopsy, a localization wire was placed and surgical Biopsy performed. There was agreement of the histologic results in 89 cases (87%) including 14 of 16 cancers (87%) (kappa = 0.806). The gun Biopsy yielded the correct diagnosis in four cases involving a lesion (including one cancer) that was missed at the surgical Biopsy. Nine cases in which the lesion was missed at gun Biopsy can be related to insufficient needle size, the greater difficulty in using one of the two stereotactic devices, and early inexperience with the technique. A 14-gauge needle was used in the last 29 biopsies, the results of which agreed with the surgical pathologic findings in 28 cases (97%). With greater experience, stereotactic-guided large-gauge automated percutaneous Biopsy may prove to be an acceptable alternative to surgical Biopsy in women with Breast masses suspected at mammography.